Status:

UNKNOWN

Construction of a Multidimensional Score for the Functional Prognosis of Cerebral Infarctions

Lead Sponsor:

Fondation Hôpital Saint-Joseph

Conditions:

Cerebral Infarction

Eligibility:

All Genders

18+ years

Brief Summary

In France, stroke is the leading cause of non-traumatic acquired motor disability in adults, the second leading cause of major cognitive impairment, and the third leading cause of death in men and wom...

Detailed Description

Data regarding the validity of poor prognostic criteria for CI are still scarce and remain of imperfect quality, particularly because of heterogeneous populations and variable definitions of "poor pro...

Eligibility Criteria

Inclusion

  • Major patients hospitalized in the Neurology-Neurovascular department of GHPSJ and discharged from hospital between January 1, 2016 and September 25, 2020.
  • Main diagnosis (MD) of CI retained by the MISP (Medicalization of Information Systems Program) grouping algorithm for the SSS (Standardized summary of stay) and defined according to the codes of the chapter "Cerebral Infarction": I63.0 to I63.5 and I63.7 to I63.9 of the ICD-10 (International Classification of Diseases, 10th revision)
  • Patients hospitalized in the NICU and for whom the passage to the NICU is the first hospitalization unit from their home or the hospitalization unit that follows a passage to the emergency department/ emergency door beds/short-term hospitalization unit (STHU)
  • Length of stay greater than or equal to 3 nights

Exclusion

  • Patient under guardianship or curatorship
  • Patient deprived of liberty
  • Patient under legal protection
  • Patient objecting to the use of his/her data for this research
  • SSS with MD I63.6 (CI due to cerebral venous thrombosis, non-pyogenic)
  • Length of stay less than or equal to 2 nights
  • Patients from other GHPSJ hospitalization units (excluding emergency department emergency, emergency door beds or STHU), or from an external establishment
  • SSS with a MD I63.0 to I63.5 or I63.7 to I63.9 not involving a passage in the NICU
  • SSS with a MD I63.0 to I63.5 or I63.7 to I63.9 involving a visit to a NICU that is neither the first hospitalization unit from home nor the hospitalization unit that follows a visit to the emergency department / emergency door beds/short-term hospitalization unit

Key Trial Info

Start Date :

April 30 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2024

Estimated Enrollment :

2091 Patients enrolled

Trial Details

Trial ID

NCT04802772

Start Date

April 30 2023

End Date

December 31 2024

Last Update

March 7 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Groupe Hospitalier Paris Saint-Joseph

Paris, Île-de-France Region, France, 75014